Choi H, Lee H, Kim T-H, Kim H J, Lee Y J, Lee S J, Yu J H, Kim D, Kim K-S, Park S W, Kim J-W
1] Department of Biochemistry and Molecular Biology, Integrated Genomic Research Center for Metabolic Regulation, Institute of Genetic Science, Yonsei University College of Medicine, Seoul, Korea [2] Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.
1] Department of Biochemistry and Molecular Biology, Integrated Genomic Research Center for Metabolic Regulation, Institute of Genetic Science, Yonsei University College of Medicine, Seoul, Korea [2] Department of Integrated OMICS for Biomedical Sciences, WCU Program of Graduate School, Yonsei University, Seoul, Korea.
Cell Death Differ. 2014 Jul;21(7):1071-80. doi: 10.1038/cdd.2014.26. Epub 2014 Feb 28.
Mouse 3T3-L1 preadipocytes differentiate into adipocytes when treated with 3-isobutyl-1-methylxanthine, dexamethasone, and insulin. Although mechanisms of adipogenesis, including transcriptional cascades, are understood, it is still unclear how clonally expanded cells eventually enter the terminal differentiation program. From gene expression profile studies, we identified G0/G1 switch gene 2 (G0s2) as a novel regulator of adipogenesis. The gene was found to be expressed at a higher level in white and brown adipose tissues, and it was induced in 3T3-L1 cells by hormonal treatment. Importantly, G0s2 expression was closely associated with the transition from mitotic clonal expansion to terminal differentiation. Knockdown of G0s2 expression with siRNA inhibited adipocyte differentiation, whereas constitutive overexpression of G0s2 accelerated differentiation of preadipocytes to mature adipocytes. Expression of G0s2 was found to be regulated by peroxisome proliferator-activated receptor γ (PPARγ), which is a well-known regulator of adipocyte differentiation. Absence of either PPARγ or G0s2 expression resulted in apoptotic pathway activation before terminal differentiation. To determine whether G0s2 has a role in vivo, G0s2-knockout mice were generated. The knockout mice were normal in appearance, but they had less adipose mass than wild-type littermates. Mouse embryonic fibroblast cells from G0s2-deficient mice exhibited impaired adipogenesis and contained unusually small intracellular lipid droplets, suggesting that G0s2 has a role in lipid droplet formation. Our studies demonstrate that G0s2 has an important role in adipogenesis and accumulation of triacylglycerol.
当用3-异丁基-1-甲基黄嘌呤、地塞米松和胰岛素处理时,小鼠3T3-L1前脂肪细胞会分化为脂肪细胞。尽管脂肪生成的机制,包括转录级联反应,已为人所知,但克隆扩增的细胞最终如何进入终末分化程序仍不清楚。通过基因表达谱研究,我们鉴定出G0/G1开关基因2(G0s2)是脂肪生成的一种新型调节因子。发现该基因在白色和棕色脂肪组织中表达水平较高,并且在激素处理下在3T3-L1细胞中被诱导表达。重要的是,G0s2的表达与从有丝分裂克隆扩增到终末分化的转变密切相关。用小干扰RNA(siRNA)敲低G0s2的表达会抑制脂肪细胞分化,而G0s2的组成型过表达则加速前脂肪细胞向成熟脂肪细胞的分化。发现G0s2的表达受过氧化物酶体增殖物激活受体γ(PPARγ)调节,PPARγ是一种众所周知的脂肪细胞分化调节因子。PPARγ或G0s2表达缺失会导致终末分化前凋亡途径激活。为了确定G0s2在体内是否起作用,我们构建了G0s2基因敲除小鼠。这些敲除小鼠外观正常,但它们的脂肪量比野生型同窝小鼠少。来自G0s2缺陷小鼠的小鼠胚胎成纤维细胞表现出脂肪生成受损,并且含有异常小的细胞内脂滴,这表明G0s2在脂滴形成中起作用。我们的研究表明,G0s2在脂肪生成和三酰甘油积累中起重要作用。